This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
DUBAI (July 20): In Dubai's posh Jumeirah Beach Residence district, luxury apartment rents are down about 15% from a year ago — a sign, some fear, that the wealthy emirate's recipe for economic success is getting stale.
McDermott International, Inc. (NYSE: MDR) and Baker Hughes, a GE company (NYSE: BHGE), have announced the award of a contract by POSCO DAEWOO Corp. for phase two of the Shwe gas field development offshore Western Myanmar.
BHI BHGE MDR MCDFF
A consortium of McDermott International, Inc. and Baker Hughes, a GE company (BHGE) has won a contract from POSCO DAEWOO Corp. for the second phase of the Shwe gas field development offshore Western Myanmar, McDermott reported Wednesday.
BHI MDR MCDFF
TULSA, Okla., June 26, 2018 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq:MTRX) — Matrix Service Company (Nasdaq:MTRX) today announced that it has appointed Liane K. Hinrichs to serve as a member of its Board of Directors following a temporary increase in Board size from seven to eight members. Ms. Hinrichs term commenced on June 5, 2018. The size of the Board will revert to seven when Board Chairman Tom E.
MTRX MDR MCDFF
Investors focused on the Oils-Energy space have likely heard of McDermott International (MDR - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
Halliburton’s (HAL) implied volatility was 25.2% on June 1. On April 23, the day Halliburton released its first-quarter earnings, its implied volatility was 24.9%. Since then, Halliburton’s implied volatility has increased marginally. Halliburton accounts for 3.1% of the SPDR S&P Oil & Gas Equipment & Services ETF (XES). XES provides exposure to the energy sector’s oil and gas equipment and services segment.
WFT MDR MCDFF
McDermott International, Inc. (MDR - Free Report) recently announced that it has clinched a transportation and installation work in Vietnam. The subcontract was offered by PetroVietnam Technical Services Corporation for the Sao Vang and Dai Nguyet gas and condensate fields, where Idemitsu Kosan Co., Ltd. is the operator. The fields are located in the Nam Con Son Basin’s 05-1b and 05-1c blocks, offshore Vietnam.
NINE DK MDR MCDFF
Halliburton’s (HAL) implied volatility was 25.4% on May 25. On April 23, the day Halliburton released its first-quarter earnings, its implied volatility was 24.9%. Since then, Halliburton’s implied volatility has increased. Halliburton accounts for 3.0% of the SPDR S&P Oil & Gas Equipment & Services ETF (XES). XES provides exposure to the energy sector’s oil and gas equipment and services segment. XES has increased 1% since April 23—compared to a 4% fall in Halliburton’s stock price during the same period.
WFT MDR MCDFF
President Donald Trump has been putting a great deal of focus on reviving the American economy. So far, he has arguably done a very good job. The big corporate tax cut will permit a lot of companies to hold onto their own money, and other than returning some of that capital to shareholders, it is in those companies’ best interests to reinvest that capital and continue to grow.
ACM MDR MLM MCDFF
Fairfax Financial’s largest five stakes are BlackBerry, Resolute Forest Products, Kennedy-Wilson, USG, and Intrepid Potash. They together account for ~85% of the US long assets.
SSYS PGH AP FRFHF CRAY PKX MLUSG RAIL NWPX SBNY GE USGPF KWN.CL RFP MDR SSWN BBRY BRK.A IPI ATUSF JNJ NTES BB SSWA MCDFF GRVVF WFCNP AGX SSW KLIC CHRRF PRAGY WFC.PRL CTL WFC.PRJ XCOOQ WFC.PRT KW RFP KWN WFC.PRR WFC.PRQ JEC WFC.PRP WFC.PRO WFC.PRN SSW.PRC SSW.PRH XCOO SSW.PRG USG WFC.PRY SSW.PRE WFC.PRX SSW.PRD WFC.PRW WFC.PRV IBM WFC WFC.WS GEC DEST BB XCO CRR ARG HP RPXC FLR GNE
HOUSTON, May 10 (Reuters) - Offshore engineering firm McDermott International Inc will close its acquisition of Chicago Bridge and Iron Co NV on Thursday, creating an integrated onshore and offshore services group that will expand its presence in the Middle East.
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
as of ET